Disrupting Cancer Diagnostics - Cloud-based Deep Learning AI for Gigantic Pathology Images
Kaisa Helminen, CEO Fimmic Oy May 11th, 2017
Disrupting Cancer Diagnostics - Cloud-based Deep Learning AI for - - PowerPoint PPT Presentation
Disrupting Cancer Diagnostics - Cloud-based Deep Learning AI for Gigantic Pathology Images Kaisa Helminen, CEO Fimmic Oy May 11th, 2017 Cancer Every third person affected 14 Million new patients in 2012 +50% more by 2030 Increasing number
Kaisa Helminen, CEO Fimmic Oy May 11th, 2017
Every third person affected 14 Million new patients in 2012 +50% more by 2030
Increasing number of samples
Lack of pathologists Increasing number of samples
designed by Freepik
Samples
Artificial Intelligence
Pathologists Researchers Any microscope scanner Educators Any device
Facial recognition
id-labs.org The Guardian
Self-driving cars Tissue diagnostics
quantification of certain cells
epithelium/stroma segmentation
samples
Enables full automation Removes extra staining step
Accurate Reproducible
Tissue Microarray
H&E of immune cell rich region Heat map showing immune cell detec7on
FIMM – Oxford collabora0on 2017, unpublished results
Digitized whole slide images of testicular cancer are huge gigabyte-sized files Areas of infiltrating immune cells detected by automated analysis includes millions of immune cells (red areas)
FIMM – Oxford collabora0on 2017, unpublished results
Automated counting result Total immune cell count = 768.349 Immune cells/square mm tumor = 4223 Details of the analysis shown in the video
FIMM – Oxford collabora0on 2017, unpublished results
Consistent Accuracy and Reproducibility over large sample sets
Quantification of nerve cell bodies from rat brain tissue (Parkinson’s, Alzheimer’s) Significant time savings:
From 45 minutes to 0,5 minutes analysis
Unforeseen Accuracy & Reproducibility
Breast cancer biomarkers: ER, Ki67, HER2 + Epithelium/stroma segmentation Prostate cancer: Gland and epithelium segmentation Lung cancer, mouse tissue: Tumor burden, tumor classification, TIL% Seminoma: TIL% Liver biopsies: Hepatosteatosis Rat brain: Nerve cell bodies (Parkinsons, ALS research) Forensic pathology: sperm detection from smears Blood: RBC, WBC, Platelets, Malaria parasites etc.
Advanced Image Storage and Collaboration tools in Cloud
Compatibility Efficient compression
Deep Learning Algorithms & Cloud computing
No local hardware Indefinite possibilities for algorithms
Disruptive business model
Affordable SaaS model for all sizes of projects
Supportive data for decision making -> Prognosis -> Suggesting treatment -> Faster, more accurate diagnosis and cure
Johan Lundin MD, CSO Co-Founder Board Member Mikael Lundin MD, Chief Data Scientist Co-Founder Board Member Kari Pitkänen Business Development Co-Founder Board Member Mikael Jääskeläinen Sales Manager Kaisa Helminen CEO Tuomas Ropponen CTO Sartorius Thermo Scientific Finnzymes Sartorius Fisher Scientific Finnzymes FIMM Fisher Scientific Finnzymes, co- founder, sold to Thermo Fisher Scientific in 2010 FIMM Karolinska Institute HUS FIMM University of Helsinki Outotec Biohit Delta-Enterprise Previously: Antti Merivirta Marketing Manager 360Visualizer Testure Finland
Combination of life science entrepreneurs, software development and machine vision experts & recognized scientists.
Kaisa Helminen, CEO +358 40 679 0669 kaisa.helminen@fimmic.com www.webmicroscope.com @kaisa_helminen